Ocutec Ltd, the has announced at the American Academy of Optometry Meeting in Orlando CE Mark approval for its first poly(ethylene) glycol (PEG) hydrogel-based contact lens product. In initial patient acceptance trials, this next generation of lenses has demonstrated superior oxygen permeability compared to existing hydrogel based lenses. It is anticipated that the lenses will provide similar health benefits to silicone hydrogels without the drawbacks of incorporating hydrophobic silicone into the lens polymer.

NeoVista, Inc. has announced that the company’s revolutionary new surgical device is now available in the UK and offers fresh hope to 250,000 patients with wet age-related macular degeneration (AMD) –- a debilitating and aggressive eye condition that can lead to blindness within 3 months if left untreated. The VIDION® Anti NeoVascular (ANV®) Therapy System has recently received a CE mark certifying that it has met the EU’s Medical Device Directive.